Literature DB >> 9082954

Serum biologic markers as predictors of disease progression in osteoarthritis of the knee.

C Georges, H Vigneron, X Ayral, V Listrat, P Ravaud, M Dougados, M Sharif, P Dieppe, T Saxne.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9082954     DOI： 10.1002/art.1780400333

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  5 in total

1.  Whole blood lead levels are associated with biomarkers of joint tissue metabolism in African American and white men and women: the Johnston County Osteoarthritis Project.

Authors:  Amanda E Nelson; Sanjay Chaudhary; Virginia B Kraus; Fang Fang; Jiu-Chiuan Chen; Todd A Schwartz; Xiaoyan A Shi; Jordan B Renner; Thomas V Stabler; Charles G Helmick; Kathleen Caldwell; A Robin Poole; Joanne M Jordan
Journal:  Environ Res       Date:  2011-08-12       Impact factor: 6.498

2.  The potential value of blood biomarkers of intervertebral disk metabolism in the follow-up of patients with sciatica.

Authors:  Federico Balagué; Margareta Nordin; Dominique Schafer; Ali Sheikhzadeh; Mary Ellen Lenz; Eugene M A Thonar
Journal:  Eur Spine J       Date:  2005-07-01       Impact factor: 3.134

3.  Effect of an exercise and dietary intervention on serum biomarkers in overweight and obese adults with osteoarthritis of the knee.

Authors:  S D Chua; S P Messier; C Legault; M E Lenz; E J-M A Thonar; R F Loeser
Journal:  Osteoarthritis Cartilage       Date:  2008-03-24       Impact factor: 6.576

4.  Study of treadmill exercise effect on rats with osteoarthritis using proteomic analysis.

Authors:  Sang Su Na; Seong Gil Kim; Min Sik Yong; Gak Hwangbo
Journal:  J Phys Ther Sci       Date:  2014-04-23

5.  Early increase in serum-COMP is associated with joint damage progression over the first five years in patients with rheumatoid arthritis.

Authors:  Maria L E Andersson; Björn Svensson; Ingemar F Petersson; Ingiäld Hafström; Kristina Albertsson; Kristina Forslind; Dick Heinegård; Tore Saxne
Journal:  BMC Musculoskelet Disord       Date:  2013-08-02       Impact factor: 2.362
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.